TY - JOUR
T1 - Preprogrammed oscillations improve lower limb blood flow and walking distance in patients with peripheral arterial disease
AU - Rabin, Igor
AU - Shpolanski, Uri
AU - Leibovitz, Allon
AU - Bass, Arie
PY - 2014/7
Y1 - 2014/7
N2 - Background: Claudication is one of the sequelae of peripheral arterial disease (PAD). To date, no effective treatment has been found for this condition. Objectives: To investigate a new device to treat PAD. The device administers pre-programmed protocols of oscillations to the foot. Methods: Fifteen patients aged 40-70 years who suffered from intermittent claudication secondary to PAD were recruited to an open prospective study. Each patient was treated once for 30 minutes. The following parameters were evaluated: pain-free and maximal walking distances, skin blood flux by laser-Doppler, skin temperature, ankle-brachial and toebrachial indices, (tcpO2) and transcutaneous carbon dioxide pressure (tcpCO2). Non-parametric signed-rank test was applied for testing differences between baseline assessment and post-treatment assessments for quantitative parameters. Results: Mean pain-free walking distance was 122 ± 33m and increased to 277 ± 67m, after the treatment session (P= 0.004). Mean maximal walking distance was 213 ± 37m and it increased to 603 ± 77m (P< 0.001). Foot skin perfusion also improved, as demonstrated by an increase in tcpO2 by 28.6 ± 4.1 mmHg (P< 0.001), a decrease in tcpCO2 by 2.8 ± 1.3(P= 0.032), and up to twofold improvement in blood flux parameters, and an increase in skin temperature by 1.9 ± 0.5°C (P< 0.001). Ankle-brachial index increased by 0.06 ± 0.01(P = 0.003) and toe-brachial index by 0.17 ± 0.02(P< 0.001). Conclusions: Preprogrammed oscillations applied to the foot had a positive effect on microcirculation, tissue oxygenation and CO2 clearance; they had a smaller though significant effect on arterial blood pressure indices, and the change in the arterial-brachial index correlated with the change in the pain-free walking distance.
AB - Background: Claudication is one of the sequelae of peripheral arterial disease (PAD). To date, no effective treatment has been found for this condition. Objectives: To investigate a new device to treat PAD. The device administers pre-programmed protocols of oscillations to the foot. Methods: Fifteen patients aged 40-70 years who suffered from intermittent claudication secondary to PAD were recruited to an open prospective study. Each patient was treated once for 30 minutes. The following parameters were evaluated: pain-free and maximal walking distances, skin blood flux by laser-Doppler, skin temperature, ankle-brachial and toebrachial indices, (tcpO2) and transcutaneous carbon dioxide pressure (tcpCO2). Non-parametric signed-rank test was applied for testing differences between baseline assessment and post-treatment assessments for quantitative parameters. Results: Mean pain-free walking distance was 122 ± 33m and increased to 277 ± 67m, after the treatment session (P= 0.004). Mean maximal walking distance was 213 ± 37m and it increased to 603 ± 77m (P< 0.001). Foot skin perfusion also improved, as demonstrated by an increase in tcpO2 by 28.6 ± 4.1 mmHg (P< 0.001), a decrease in tcpCO2 by 2.8 ± 1.3(P= 0.032), and up to twofold improvement in blood flux parameters, and an increase in skin temperature by 1.9 ± 0.5°C (P< 0.001). Ankle-brachial index increased by 0.06 ± 0.01(P = 0.003) and toe-brachial index by 0.17 ± 0.02(P< 0.001). Conclusions: Preprogrammed oscillations applied to the foot had a positive effect on microcirculation, tissue oxygenation and CO2 clearance; they had a smaller though significant effect on arterial blood pressure indices, and the change in the arterial-brachial index correlated with the change in the pain-free walking distance.
KW - Blood flow
KW - Claudication
KW - Oscillations
KW - Peripheral arterial disease
KW - Walking distance
UR - http://www.scopus.com/inward/record.url?scp=84905637966&partnerID=8YFLogxK
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
AN - SCOPUS:84905637966
SN - 1565-1088
VL - 16
SP - 423
EP - 426
JO - Israel Medical Association Journal
JF - Israel Medical Association Journal
IS - 7
ER -